Therefore, we statistically analyzed the changes of RIG-G gene, PML-RARα/ABL (%), Blast (%) before and after ATRA treatment in each APL patient (Figure 5C–E). This evidence concerns the gene IFIT3 and acute promyelocytic leukemia.